HomeTOP STORIESCogent surges as bezuclastinib meets key goal in phase 2 mastocytosis trial Cogent surges as bezuclastinib meets key goal in phase 2 mastocytosis trial By rogerjudd July 7, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleWhat Happens When Most of the Adults in Boys’ Lives Are WomenNext articleApogee falls after results from atopic dermatitis trial latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
